Kurt Forrer

Novartis (Switzerland)

Papers

1

Total Citations

47

H-Index

1

About

Kurt Forrer is a distinguished biopharmaceutical researcher whose work centers on the high-throughput development and formulation of therapeutic antibodies. His major contribution lies in pioneering automated, robotic systems that dramatically accelerate the formulation process for biologic drugs, a critical step in bringing life-saving treatments to patients. His most-cited paper, "Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)" (2009, 47 citations), exemplifies this innovation, demonstrating how miniaturized, parallel experimentation can replace traditional labor-intensive methods. This work has had a lasting impact on the field, providing a blueprint for efficient drug development pipelines. Forrer’s achievements are notable for bridging the gap between laboratory science and industrial-scale production, enabling faster identification of stable, effective antibody formulations. His research continues to influence how pharmaceutical companies approach the complex challenge of protein stability, making him a key figure in modern bioprocessing and a valuable resource for students and researchers interested in the intersection of automation and biologics.

Research Focus

Key Achievements

1
H-Index
1
Papers
47
Total Citations
47
Avg Citations/Paper
🏆 Most Cited Paper
Formulation Development of Antibodies Using Robotic System and High-Throughput Laboratory (HTL)
47 citations · 2009
📈 Most Prolific Year: 2009 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Novartis (Switzerland)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago